From Editor: Introducing a New Journal Dedicated to Clinical Oncology and Therapeutics

Abstract

Within the last few years, the technologies in the field of clinical oncology are developing rapidly and we have seen an explosion in knowledge of the biologic drivers of cancer.
Most of the tumors are now sub-classified by a molecular profile, with different treatment options and strategies for patients based on their tumor biomarker status. For example, some tumors can be treated with highly sophisticated precision external beam radiation therapy such as proton beam therapy